0,819  0,009  Caspase 9 stimulant
0,787  0,008  Antineoplastic (colorectal cancer)
0,782  0,008  Antineoplastic (colon cancer)
0,759  0,005  Antineoplastic (non-small cell lung cancer)
0,720  0,016  Antineoplastic (lung cancer)
0,692  0,006  Caspase 3 stimulant
0,654  0,009  Antineoplastic (melanoma)
0,642  0,006  CYP2C19 inhibitor
0,644  0,014  Prostate cancer treatment
0,620  0,017  Antineoplastic (solid tumors)
0,605  0,014  5 Hydroxytryptamine release stimulant
0,603  0,015  Antineoplastic (ovarian cancer)
0,582  0,005  Tubulin antagonist
0,598  0,035  Antineoplastic (breast cancer)
0,605  0,048  Apoptosis agonist
0,561  0,008  Antineoplastic (glioblastoma multiforme)
0,559  0,012  Antineoplastic (glioma)
0,559  0,012  Antineoplastic (multiple myeloma)
0,548  0,006  Antineoplastic (renal cancer)
0,535  0,010  Antimitotic
0,525  0,006  Muscle relaxant
0,525  0,012  DNA damaging
0,511  0,005  DNA intercalator
0,511  0,011  Antineoplastic (lymphoma)
0,499  0,004  Topoisomerase I inhibitor
0,484  0,006  Male reproductive disfunction treatment
0,480  0,005  Skeletal muscle relaxant
0,495  0,023  Antineoplastic (cervical cancer)
0,474  0,005  Erectile dysfunction treatment
0,470  0,004  NADPH oxidase inhibitor
0,500  0,039  Antileukemic
0,489  0,030  Respiratory analeptic
0,470  0,017  Cardiodepressant
0,484  0,044  15-Lipoxygenase inhibitor
0,432  0,005  Alpha 2 adrenoreceptor antagonist
0,433  0,009  Topoisomerase II inhibitor
0,435  0,014  Antineoplastic (small cell lung cancer)
0,440  0,026  CYP2D6 inhibitor
0,428  0,016  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,413  0,004  Carcinogenic, group 1
0,413  0,009  5 Hydroxytryptamine 2 antagonist
0,412  0,032  Cytostatic
0,403  0,029  Hypoxia-inducible factor 1 alpha inhibitor
0,372  0,004  LDLR expression enhancer
0,372  0,008  5 Hydroxytryptamine 2A antagonist
0,361  0,005  CDC-like kinase 1 inhibitor
0,396  0,041  Spasmolytic
0,389  0,035  CYP3A4 inhibitor
0,390  0,042  Antineoplastic (brain cancer)
0,362  0,014  Antineoplastic (squamous cell carcinoma)
0,363  0,026  Antineoplastic (lymphocytic leukemia)
0,364  0,028  Sigma receptor agonist
0,378  0,043  Vasodilator, coronary
0,350  0,024  Antiparkinsonian, rigidity relieving
0,347  0,025  Sedative
0,335  0,015  5 Hydroxytryptamine antagonist
0,329  0,010  Acetylcholinesterase inhibitor
0,371  0,060  Mood disorders treatment
0,323  0,014  Alpha adrenoreceptor antagonist
0,341  0,037  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,359  0,057  Antidepressant
0,316  0,017  Cholinergic
0,302  0,010  Heat shock protein 90 antagonist
0,305  0,014  Bipolar disorder treatment
0,296  0,006  Dopamine D1 antagonist
0,310  0,020  Antineoplastic (carcinoma)
0,322  0,032  Antineoplastic (sarcoma)
0,322  0,034  Cyclic AMP phosphodiesterase inhibitor
0,298  0,010  Butyrylcholinesterase inhibitor
0,304  0,017  Neurotrophic factor enhancer
0,338  0,054  CYP1A2 substrate
0,315  0,035  Clk dual-specificity kinase inhibitor
0,324  0,047  Antiprotozoal (Leishmania)
0,333  0,057  Analeptic
0,366  0,092  Histamine release inhibitor
0,322  0,049  Antiprotozoal (Trypanosoma)
0,275  0,004  Alpha tubulin antagonist
0,316  0,047  Dyrk kinase inhibitor
0,275  0,008  Alpha 2a adrenoreceptor antagonist
0,311  0,049  Tumour necrosis factor alpha release inhibitor
0,312  0,050  Radiosensitizer
0,263  0,004  CDC-like kinase 3 inhibitor
0,346  0,102  TNF expression inhibitor
0,247  0,010  Alpha 2c adrenoreceptor antagonist
0,239  0,005  Antineoplastic alkaloid
0,269  0,037  VCAM1 expression inhibitor
0,275  0,046  Antihypertriglyceridemic
0,307  0,078  Hepatic disorders treatment
0,263  0,037  P-glycoprotein inhibitor
0,315  0,089  Vasodilator, peripheral
0,231  0,005  Phosphodiesterase V inhibitor
0,264  0,039  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,242  0,022  Antineoplastic (bone cancer)
0,237  0,017  Alpha 2b adrenoreceptor antagonist
0,232  0,011  Topoisomerase II alpha inhibitor
0,226  0,006  Beta tubulin antagonist
0,271  0,053  5 Hydroxytryptamine 1E antagonist
0,233  0,016  Dopamine antagonist
0,250  0,037  CYP2B6 inhibitor
0,216  0,004  Phosphodiesterase 11A inhibitor
0,216  0,004  Phosphodiesterase XI inhibitor
0,279  0,068  CYP1A2 inhibitor
0,229  0,019  Phobic disorders treatment
0,274  0,064  NOS2 expression inhibitor
0,238  0,031  Antiparkinsonian, tremor relieving
0,233  0,033  Heat shock protein 90 alpha antagonist
0,211  0,014  5 Hydroxytryptamine 1A antagonist
0,201  0,006  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,210  0,016  5 Hydroxytryptamine 1 antagonist
0,279  0,087  Anxiolytic
0,198  0,006  Phosphodiesterase 5A inhibitor
0,204  0,013  Breast cancer-resistant protein inhibitor
0,214  0,024  5 Hydroxytryptamine 2B antagonist
0,237  0,047  Hepatoprotectant
0,223  0,034  5 Hydroxytryptamine 3E antagonist
0,249  0,061  Pyruvate kinase inhibitor
0,201  0,015  MAP3K9 inhibitor
0,194  0,010  Carcinogenic, group 2A
0,233  0,051  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,275  0,094  CYP2D6 substrate
0,216  0,035  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,196  0,017  Dopamine D2 antagonist
0,249  0,073  Antineoplastic (liver cancer)
0,255  0,086  Antineurogenic pain
0,196  0,030  Psychosexual dysfunction treatment
0,201  0,035  Genotoxic
0,200  0,037  ATPase inhibitor
0,252  0,092  Antineoplastic (pancreatic cancer)
0,251  0,092  Antipsychotic
0,180  0,024  Alpha 1 adrenoreceptor antagonist
0,167  0,013  Dopamine D3 antagonist
0,156  0,003  Factor III inhibitor
0,212  0,062  CDC-like kinase 4 inhibitor
0,200  0,053  Antineoplastic (gastric cancer)
0,165  0,019  Calcium antagonist
0,312  0,167  MAP kinase 1 inhibitor
0,164  0,021  DNA repair enzyme inhibitor
0,208  0,067  Pneumotoxic
0,260  0,120  Transcription factor NF kappa B inhibitor
0,261  0,124  CYP3A4 substrate
0,226  0,090  Antipyretic
0,224  0,089  DNA synthesis inhibitor
0,301  0,166  Alzheimer's disease treatment
0,176  0,049  Activin receptor-like kinase 2 inhibitor
0,212  0,088  Free radical scavenger
0,175  0,052  Attention deficit/hyperactivity disorder treatment
0,150  0,028  Activin receptor-like kinase 4 inhibitor
0,153  0,032  Antineoplastic (uterine cancer)
0,209  0,088  RNA-directed DNA polymerase inhibitor
0,130  0,010  Phosphodiesterase VI inhibitor
0,222  0,101  Tyrosine 3 hydroxylase inhibitor
0,143  0,024  Alpha 1a adrenoreceptor antagonist
0,226  0,109  UGT2B4 substrate
0,151  0,035  Antiadrenergic
0,121  0,005  Endothelin receptor antagonist
0,265  0,150  Antiprotozoal
0,157  0,042  Antiviral (Hepatitis B)
0,118  0,005  Glutamate (mGluR7) antagonist
0,147  0,035  Adrenaline antagonist
0,289  0,177  5 Hydroxytryptamine release inhibitor
0,190  0,079  Abortion inducer
0,128  0,019  Phosphodiesterase 6D inhibitor
0,155  0,046  Antiprotozoal (Trichomonas)
0,178  0,069  Tumour necrosis factor antagonist
0,214  0,105  Antioxidant
0,240  0,132  Prostaglandin dehydrogenase inhibitor
0,207  0,099  Vasodilator
0,173  0,065  Antimutagenic
0,237  0,132  Antineoplastic (osteosarcoma)
0,190  0,085  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,143  0,043  MAO A inhibitor
0,102  0,004  Ryanodine receptor antagonist
0,211  0,118  Antineoplastic (bladder cancer)
0,114  0,024  ATPase (Vacuolar H+) inhibitor
0,096  0,008  5 Hydroxytryptamine 7 agonist
0,228  0,141  Antihypertensive
0,160  0,073  Uterine stimulant
0,226  0,138  GST M1-1 substrate
0,153  0,066  Protein kinase stimulant
0,116  0,030  Alpha 1b adrenoreceptor antagonist
0,088  0,005  Endothelin A receptor antagonist
0,099  0,016  5 Hydroxytryptamine 5A antagonist
0,193  0,109  Antihypercholesterolemic
0,162  0,079  UGT2B10 substrate
0,148  0,066  MAP kinase kinase 4 inhibitor
0,153  0,071  Acetylcholine M1 receptor antagonist
0,096  0,016  5 Hydroxytryptamine 5 antagonist
0,107  0,026  mTOR complex 2 inhibitor
0,084  0,004  Endothelin B receptor antagonist
0,246  0,168  CYP2C9 inhibitor
0,141  0,065  MAO inhibitor
0,132  0,057  Papain-like protease (SARS coronavirus) inhibitor
0,167  0,097  Amyloid beta aggregation inhibitor
0,137  0,067  Phosphodiesterase inhibitor
0,098  0,030  Acetylcholine M4 receptor antagonist
0,127  0,062  Alkylator
0,196  0,133  UGT1A9 substrate
0,191  0,130  Radioprotector
0,146  0,086  Melanin inhibitor
0,224  0,167  Antiprotozoal (Plasmodium)
0,227  0,170  CYP2C9 substrate
0,191  0,135  Proliferative diseases treatment
0,170  0,115  VEGF expression inhibitor
0,203  0,148  12-Lipoxygenase inhibitor
0,090  0,036  Glutamate decarboxylase inhibitor
0,144  0,090  Mutagenic
0,071  0,018  Bcl-xL inhibitor
0,160  0,107  Psychostimulant
0,060  0,008  Phosphodiesterase 6C inhibitor
0,076  0,024  Heat shock protein 90 beta antagonist
0,115  0,063  Sphingosine 1-phosphate receptor 2 agonist
0,192  0,140  Cardioprotectant
0,143  0,093  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,067  0,018  Topoisomerase II beta inhibitor
0,083  0,035  Antitreponemal
0,079  0,032  Endocannabinoid uptake inhibitor
0,193  0,148  Lipoxygenase inhibitor
0,084  0,040  5 Hydroxytryptamine agonist
0,119  0,075  Antiseptic
0,069  0,028  Potassium channel (Ca-activated) blocker
0,064  0,024  5 Hydroxytryptamine 1A agonist
0,047  0,008  Phosphodiesterase 6B inhibitor
0,063  0,024  5 Hydroxytryptamine 2 agonist
0,075  0,036  Female sexual dysfunction treatment
0,176  0,138  Hypoglycemic
0,214  0,176  FMO1 substrate
0,090  0,053  5 Hydroxytryptamine 2C antagonist
0,135  0,097  Heat shock protein 70 antagonist
0,138  0,102  CDC-like kinase 2 inhibitor
0,091  0,057  Antiviral (Hepatitis A)
0,119  0,085  Sodium channel (voltage-gated) blocker
0,103  0,069  DOPA decarboxylase inhibitor
0,038  0,005  Imidazoline I1 receptor antagonist
0,074  0,041  Dopamine agonist
0,144  0,112  Aldehyde oxidase substrate
0,054  0,023  Dopamine D5 antagonist
0,192  0,162  Bone diseases treatment
0,093  0,065  Obsessive-compulsive disorder treatment
0,145  0,117  Septic shock treatment
0,051  0,024  Potassium channel small-conductance Ca-activated blocker
0,046  0,020  Acid-sensing ion channel blocker
0,136  0,110  Nitric oxide antagonist
0,031  0,007  Phosphodiesterase 6G inhibitor
0,031  0,007  Phosphodiesterase 6H inhibitor
0,114  0,092  Sodium channel blocker
0,124  0,101  Chemopreventive
0,133  0,112  Prostate disorders treatment
0,059  0,038  Alpha 1 adrenoreceptor agonist
0,067  0,047  Acetylcholine M5 receptor agonist
0,076  0,057  Macrophage migration inhibitory factor inhibitor
0,090  0,072  Sphingomyelinase inhibitor
0,138  0,120  Platelet adhesion inhibitor
0,048  0,031  Benzodiazepine antagonist
0,076  0,059  MAP kinase 7 inhibitor
0,059  0,042  HIV-1 integrase (Strand Transfer) inhibitor
0,096  0,081  GABA receptor agonist
0,096  0,082  Polo-like kinase-4 inhibitor
0,107  0,094  Cyclooxygenase 3 inhibitor
0,083  0,070  Phosphodiesterase I inhibitor
0,088  0,076  Carcinogenic, group 2B
0,016  0,004  Imidazoline I2 receptor antagonist
0,025  0,013  Phosphodiesterase 6A inhibitor
0,037  0,029  Vesicle monoamine transporter inhibitor
0,057  0,048  5 Hydroxytryptamine 7 antagonist
0,023  0,015  Dopamine D1 agonist
0,100  0,091  Microtubule formation inhibitor
0,033  0,025  Transforming growth factor beta 2 antagonist
0,054  0,046  Alpha 1d adrenoreceptor antagonist
0,059  0,051  Antiviral (Parainfluenza)
0,066  0,059  Phosphodiesterase 4D inhibitor
0,192  0,186  CTGF expression inhibitor
0,110  0,104  Antifungal enhancer
0,206  0,200  GABA C receptor rho-3 antagonist
0,094  0,089  Protein kinase C gamma inhibitor
0,064  0,060  Telomerase inhibitor
0,138  0,135  Antiviral (Hepatitis)
0,097  0,094  Acetylcholine muscarinic antagonist
0,087  0,085  Falcipain 3 inhibitor
0,082  0,081  Restless leg syndrome treatment

